Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor (Q45000490)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor |
scientific article |
Statements
1 reference
Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor (English)
1 reference
1 reference
1 reference
1 reference
Alex Sparreboom
1 reference
Antoinette R Tan
1 reference
Xiaowei Yang
1 reference
Arlene Berman
1 reference
Erin R Lepper
1 reference
Allyson L Parr
1 reference
William D Figg
1 reference
Catherine Chow
1 reference
Seth M Steinberg
1 reference
Stephen L Bacharach
1 reference
Millie Whatley
1 reference
Jaime S Brahim
1 reference
Seth A Ettenberg
1 reference
Stan Lipkowitz
1 reference
1 August 2004
1 reference
1 reference
Identifiers
1 reference